Skip to main content
SpringerLink
Log in

Rare Tumors and Benign Diseases

  • Chapter
  • First Online:
Radiation Oncology

  • 2714 Accesses

Abstract

This book, arranged in an MCQ format complemented by oral exam questions, is designed to meet the needs of a wide range of examinees. Essential aspects of radiation physics, radiobiology, and clinical radiation oncology are well covered. Tumors at different sites are addressed in a series of individual chapters, and further chapters are devoted to lymphomas and total body irradiation, pediatric tumors, and rare tumors and benign diseases. The answer keys provide clear explanations for both the correct answers and incorrect statements.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bradley EA, Gower EW, Bradley DJ, Meyer DR, Cahill KV, Custer PL et al (2008) Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology. Ophthalmology 115(2):398–409

    Article  PubMed  Google Scholar 

  2. Prummel MF, Mourits MP, Blank L, Berghout A, Koornneef L, Wiersinga WM (1993) Randomized double-blind trial of prednisone versus radiotherapy in Graves’ ophthalmopathy. Lancet 342(8877):949–954

    Article  PubMed  CAS  Google Scholar 

  3. Prummel MF, Terwee CB, Gerding MN, Baldeschi L, Mourits MP, Blank L et al (2004) A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves’ ophthalmopathy. J Clin Endocrinol Metab 89(1):15–20

    Article  PubMed  CAS  Google Scholar 

  4. Wakelkamp IM, Tan H, Saeed P, Schlingemann RO, Verbraak FD, Blank LE et al (2004) Orbital irradiation for Graves’ ophthalmopathy: is it safe? A long-term follow-up study. Ophthalmology 111(8):1557–1562

    Article  PubMed  Google Scholar 

  5. Chole R, Patil R, Degwekar SS, Bhowate RR (2007) Drug treatment of trigeminal neuralgia: a systematic review of the literature. J Oral Maxillofac Surg 65(1):40–45

    Article  PubMed  Google Scholar 

  6. Spatz AL, Zakrzewska JM, Kay EJ (2007) Decision analysis of medical and surgical treatments for trigeminal neuralgia: how patient evaluations of benefits and risks affect the utility of treatment decisions. Pain 131(3):302–310

    Article  PubMed  CAS  Google Scholar 

  7. Brisman R (2007) Microvascular decompression vs. gamma knife radiosurgery for typical trigeminal neuralgia: preliminary findings. Stereotact Funct Neurosurg 85(2–3):94–98

    Article  PubMed  Google Scholar 

  8. Cheng JS, Sanchez-Mejia RO, Limbo M, Ward MM, Barbaro NM (2005) Management of medically refractory trigeminal neuralgia in patients with multiple sclerosis. Neurosurg Focus 18(5):e13

    Article  PubMed  Google Scholar 

  9. Spetzler RF, Martin NA (1986) A proposed grading system for arteriovenous malformations. J Neurosurg 65(4):476–483

    Article  PubMed  CAS  Google Scholar 

  10. Brown RD Jr (2000) Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery 46(4):1024

    PubMed  Google Scholar 

  11. Kondziolka D, McLaughlin MR, Kestle JR (1995) Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery 37(5):851–855

    Article  PubMed  CAS  Google Scholar 

  12. Maruyama K, Kawahara N, Shin M, Tago M, Kishimoto J, Kurita H et al (2005) The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 352(2):146–153

    Article  PubMed  CAS  Google Scholar 

  13. Pollock BE, Meyer FB (2004) Radiosurgery for arteriovenous malformations. J Neurosurg 101(3):390–392; discussion 2

    Article  PubMed  Google Scholar 

  14. Flickinger JC, Pollock BE, Kondziolka D, Lunsford LD (1996) A dose–response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys 36(4):873–879

    Article  PubMed  CAS  Google Scholar 

  15. Karlsson B, Lindquist C, Steiner L (1997) Prediction of obliteration after gamma knife surgery for cerebral arteriovenous malformations. Neurosurgery 40(3):425–430; discussion 430–431

    PubMed  CAS  Google Scholar 

  16. Hartmann A, Pile-Spellman J, Stapf C, Sciacca RR, Faulstich A, Mohr JP et al (2002) Risk of endovascular treatment of brain arteriovenous malformations. Stroke 33(7):1816–1820

    Article  PubMed  CAS  Google Scholar 

  17. Starke RM, Komotar RJ, Otten ML, Hahn DK, Fischer LE, Hwang BY et al (2009) Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits. Stroke 40(8):2783–2790

    Article  PubMed  CAS  Google Scholar 

  18. Ogilvy CS, Stieg PE, Awad I, Brown RD Jr, Kondziolka D, Rosenwasser R et al (2001) AHA Scientific Statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 32(6):1458–1471

    Article  PubMed  CAS  Google Scholar 

  19. Ogilvy CS, Stieg PE, Awad I, Brown RD Jr, Kondziolka D, Rosenwasser R et al (2001) Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Circulation 103(21):2644–2657

    PubMed  CAS  Google Scholar 

  20. Pakos EE, Ioannidis JP (2004) Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys 60(3):888–895

    Article  PubMed  CAS  Google Scholar 

  21. Seegenschmiedt MH, Makoski HB, Micke O (2001) Radiation prophylaxis for heterotopic ossification about the hip joint – a multicenter study. Int J Radiat Oncol Biol Phys 51(3):756–765

    Article  PubMed  CAS  Google Scholar 

  22. Kal HB, Veen RE (2005) Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Dose-effect relationship. Strahlenther Onkol 181(11):717–723

    Article  PubMed  Google Scholar 

  23. Flickinger JC (2011) A radiobiological analysis of multicenter data for postoperative keloid radiotherapy. Int J Radiat Oncol Biol Phys 79(4):1164–1170

    Article  PubMed  Google Scholar 

  24. Di Lorenzo G, Autorino R, Perdona S, De Placido S (2005) Management of gynaecomastia in patients with prostate cancer: a systematic review. Lancet Oncol 6(12):972–979

    Article  PubMed  Google Scholar 

  25. Di Lorenzo G, Perdona S, De Placido S, D’Armiento M, Gallo A, Damiano R et al (2005) Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy. J Urol 174(6):2197–2203

    Article  PubMed  Google Scholar 

  26. Perdona S, Autorino R, De Placido S, D’Armiento M, Gallo A, Damiano R et al (2005) Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol 6(5):295–300

    Article  PubMed  CAS  Google Scholar 

  27. El-Sakka AI, Yassin AA (2008) Conservative treatment for Peyronie’s disease: an update. Expert Opin Pharmacother 9(1):53–63

    Article  PubMed  CAS  Google Scholar 

  28. Incrocci L, Hop WC, Seegenschmiedt HM (2008) Radiotherapy for Peyronie’s disease: a European survey. Acta Oncol 47(6):1110–1112

    Article  PubMed  Google Scholar 

  29. Incrocci L, Hop WC, Slob AK (2000) Current sexual functioning in 106 patients with Peyronie’s disease treated with radiotherapy 9 years earlier. Urology 56(6):1030–1034

    Article  PubMed  CAS  Google Scholar 

  30. Incrocci L, Wijnmaalen A, Slob AK, Hop WC, Levendag PC (2000) Low-dose radiotherapy in 179 patients with Peyronie’s disease: treatment outcome and current sexual functioning. Int J Radiat Oncol Biol Phys 47(5):1353–1356

    Article  PubMed  CAS  Google Scholar 

  31. Niewald M, Wenzlawowicz KV, Fleckenstein J, Wisser L, Derouet H, Rube C (2006) Results of radiotherapy for Peyronie’s disease. Int J Radiat Oncol Biol Phys 64(1):258–262

    Article  PubMed  Google Scholar 

  32. Seegenschmiedt MH, Katalinic A, Makoski H, Haase W, Gademann G, Hassenstein E (2000) Radiation therapy for benign diseases: patterns of care study in Germany. Int J Radiat Oncol Biol Phys 47(1):195–202

    Article  PubMed  CAS  Google Scholar 

  33. Muecke R, Micke O, Reichl B, Heyder R, Prott FJ, Seegenschmiedt MH et al (2007) Demographic, clinical and treatment related predictors for event-free probability following low-dose radiotherapy for painful heel spurs – a retrospective multicenter study of 502 patients. Acta Oncol 46(2):239–246

    Article  PubMed  Google Scholar 

  34. Heyd R, Tselis N, Ackermann H, Roddiger SJ, Zamboglou N (2007) Radiation therapy for painful heel spurs: results of a prospective randomized study. Strahlenther Onkol 183(1):3–9

    Article  PubMed  Google Scholar 

  35. Surenkok S, Dirican B, Beyzadeoglu M, Oysul K (2006) Heel spur radiotherapy and radiation carcinogenesis risk estimation. Radiat Med 24(8):573–576

    Article  PubMed  Google Scholar 

  36. Kollert M, Minovi A, Mangold R, Hendus J, Draf W, Bockmuhl U (2006) Paraganglioma of the head and neck–tumor control, functional results and quality of life. Laryngorhinootologie 85(9):649–656

    Article  PubMed  CAS  Google Scholar 

  37. Semaan MT, Megerian CA (2008) Current assessment and management of glomus tumors. Curr Opin Otolaryngol Head Neck Surg 16(5):420–426

    Article  PubMed  Google Scholar 

  38. Martin JJ, Kondziolka D, Flickinger JC, Mathieu D, Niranjan A, Lunsford LD (2007) Cranial nerve preservation and outcomes after stereotactic radiosurgery for jugular foramen schwannomas. Neurosurgery 61(1):76–81; discussion 81

    Article  PubMed  Google Scholar 

  39. Lim M, Bower R, Nangiana JS, Adler JR, Chang SD (2007) Radiosurgery for glomus jugulare tumors. Technol Cancer Res Treat 6(5):419–423

    PubMed  Google Scholar 

  40. Li G, Chang S, Adler JR Jr, Lim M (2007) Irradiation of glomus jugulare tumors: a historical perspective. Neurosurg Focus 23(6):E13

    Article  PubMed  Google Scholar 

  41. Krych AJ, Foote RL, Brown PD, Garces YI, Link MJ (2006) Long-term results of irradiation for paraganglioma. Int J Radiat Oncol Biol Phys 65(4):1063–1066

    Article  PubMed  Google Scholar 

  42. Acciarri N, Galassi E, Giulioni M, Pozzati E, Grasso V, Palandri G et al (2009) Cavernous malformations of the central nervous system in the pediatric age group. Pediatr Neurosurg 45(2):81–104

    Article  PubMed  Google Scholar 

  43. Hasegawa T, McInerney J, Kondziolka D, Lee JY, Flickinger JC, Lunsford LD (2002) Long-term results after stereotactic radiosurgery for patients with cavernous malformations. Neurosurgery 50(6):1190–1197; discussion 7–8

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MD Anderson Cancer Center, University of Texas, Istanbul, Turkey

    Ugur Selek MD (Adjunct Associate Professor of Radiation Oncology)

  2. MD Anderson Radiation Oncology, Center at American Hospital-Istanbul Nisantasi, Istanbul, Turkey

    Ugur Selek MD (Chief)

  3. Department of Radiation, Gulhane Military Medical School, Etlik, Ankara, Turkey

    Murat Beyzadeoglu MD (Professor and Chairman of Radiation Oncology)

  4. Department of Radiation Oncology Faculty of Medicine, Hacettepe University, Sihhiye, Ankara, Turkey

    Gokhan Ozyigit MD (Associate Professor of Radiation Oncology)

Authors
  1. Ugur Selek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ugur Selek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Murat Beyzadeoglu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gokhan Ozyigit MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Selek, U., Selek, U., Beyzadeoglu, M., Ozyigit, G. (2012). Rare Tumors and Benign Diseases. In: Radiation Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27988-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27988-1_15

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-27987-4

  • Online ISBN: 978-3-642-27988-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation